Author

Eric Barlandas-Rendón

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

A-004 Association between chronic hyperglycemia and elevated cardiovascular risk: A multivariate analysis in type 2 diabetes

The reduction of cardiovascular morbidity and the prevention of premature mortality constitute the therapeutic cornerstones in the management of type 2 diabetes mellitus. While conventional clinical approaches have historically prioritized the optimization of anthropometric parameters and lipid profiles, contempo...

Eric Barlandas-Rendón, David Emmanuel Zacarias-Huerta, S. Quintana-Ponce et al. · Clinical Chemistry · 0 citations

Oct 2026

A-191 RISK FACTORS ASSOCIATED WITH THE DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH DIABETES

Diabetic nephropathy is a complication of type 2 diabetes mellitus associated with reduced glomerular filtration rate and increased albuminuria. The Kidney Disease, Improving Global Outcomes (KDIGO) 2012 classification integrates estimated glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (ACR) to...

Eric Barlandas-Rendón, Eduardo Vera-Vivanco, S. Quintana-Ponce et al. · Clinical Chemistry · 0 citations

Oct 2026

A-003 Cardiovascular risk factors in patients with DM2; differences by gender.

Type 2 diabetes mellitus (T2DM) significantly increases cardiovascular risk (CVR). However, the burden of cardiovascular risk factors (CVRFs) and their clinical impact vary critically according to sex, requiring differentiated diagnostic approaches in laboratory medicine. The objective of this study was to evalua...

Eric Barlandas-Rendón, Gloria Abigail Pelaez-Rosas, S. Quintana-Ponce et al. · Clinical Chemistry · 0 citations